Profile | GDS4284 / 202882_x_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 10445.8 | 97 |
GSM687648 | Patient 402 control | 8113.35 | 96 |
GSM687653 | Patient 403 control | 11232.1 | 97 |
GSM687658 | Patient 404 control | 9040.68 | 97 |
GSM687663 | Patient 411 control | 7728.34 | 96 |
GSM687668 | Patient 422 control | 10307.3 | 97 |
GSM687673 | Patient 424 control | 7346.28 | 96 |
GSM687678 | Patient 425 control | 7944.9 | 96 |
GSM687683 | Patient 427 control | 7306.43 | 96 |
GSM687688 | Patient 428 control | 12761.3 | 98 |
GSM687695 | Patient 441 control | 4085.5 | 92 |
GSM687699 | Patient 443 control | 7231.59 | 96 |
GSM687704 | Patient 444 control | 7879.51 | 96 |
GSM687707 | Patient 448 control | 10677.1 | 97 |
GSM687712 | Patient 449 control | 11011.2 | 97 |
GSM687719 | Patient 450 control | 8351.36 | 96 |
GSM687724 | Patient 451 control | 7835.9 | 96 |
GSM687728 | Patient 452 control | 6319.82 | 95 |
GSM687646 | Patient 401 treated 24h | 11076.7 | 98 |
GSM687649 | Patient 402 treated 24h | 7422.4 | 96 |
GSM687665 | Patient 411 treated 24h | 7726.47 | 96 |
GSM687651 | Patient 402 treated 4 weeks | 7803.64 | 96 |
GSM687667 | Patient 411 treated 4 weeks | 8684.65 | 97 |
GSM687670 | Patient 422 treated 24h | 9666.31 | 97 |
GSM687671 | Patient 422 treated 4 weeks | 8971.89 | 97 |
GSM687654 | Patient 403 treated 24h | 10715.3 | 97 |
GSM687675 | Patient 424 treated 24h | 7644.33 | 96 |
GSM687685 | Patient 427 treated 24h | 7930.61 | 96 |
GSM687656 | Patient 403 treated 4 weeks | 10075.3 | 97 |
GSM687677 | Patient 424 treated 4 weeks | 7556.67 | 96 |
GSM687687 | Patient 427 treated 4 weeks | 9044.89 | 97 |
GSM687692 | Patient 428 treated 4h | 10495.2 | 97 |
GSM687716 | Patient 449 treated 4h | 10412.7 | 97 |
GSM687722 | Patient 450 treated 4h | 7965.21 | 96 |
GSM687680 | Patient 425 treated 24h | 8332.37 | 96 |
GSM687690 | Patient 428 treated 24h | 10254.1 | 97 |
GSM687700 | Patient 443 treated 24h | 6889.72 | 96 |
GSM687705 | Patient 444 treated 24h | 11271.6 | 97 |
GSM687714 | Patient 449 treated 24h | 11485.9 | 97 |
GSM687721 | Patient 450 treated 24h | 8419.2 | 96 |
GSM687682 | Patient 425 treated 4 weeks | 7343.18 | 96 |
GSM687694 | Patient 428 treated 4 weeks | 10046.1 | 97 |
GSM687702 | Patient 443 treated 4 weeks | 8578.84 | 97 |
GSM687718 | Patient 449 treated 4 weeks | 11844.8 | 97 |
GSM687723 | Patient 450 treated 4 weeks | 9561.27 | 97 |
GSM687661 | Patient 404 treated 4h | 9883.33 | 97 |
GSM687710 | Patient 448 treated 4h | 8454.88 | 96 |
GSM687726 | Patient 451 treated 4h | 7476.73 | 96 |
GSM687730 | Patient 452 treated 4h | 3726.22 | 92 |
GSM687660 | Patient 404 treated 24h | 7911.56 | 96 |
GSM687697 | Patient 441 treated 24h | 4201.2 | 92 |
GSM687709 | Patient 448 treated 24h | 11052.6 | 97 |
GSM687725 | Patient 451 treated 24h | 8638.55 | 96 |
GSM687729 | Patient 452 treated 24h | 4905.47 | 93 |
GSM687727 | Patient 451 treated 4 weeks | 7380.1 | 96 |
GSM687731 | Patient 452 treated 4 weeks | 6635.52 | 95 |